Relevant bibliographies by topics / Pharma marketing

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Pharma marketing'

Author: Grafiati
Published: 4 June 2021
Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharma marketing.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharma marketing"

1

Jeffreys, Diarmund. "4th Annual Pharmaceutical Marketing Conference ‘Marketing ROI for Pharma’." Journal of Medical Marketing 5, no. 2 (April 1, 2005): 182. http://dx.doi.org/10.1057/palgrave.jmm.5040226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Röleke, Dietmar. "Aus dem Labor ins Pharma-Marketing." Nachrichten aus der Chemie 53, no. 9 (September 2005): 976–77. http://dx.doi.org/10.1002/nadc.20050530954.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Behnke, Nils. "Marketing Strategy: How biotechnology and speciality pharma companies can beat big pharma in marketing cancer drugs." Journal of Medical Marketing 5, no. 1 (January 1, 2005): 10–14. http://dx.doi.org/10.1057/palgrave.jmm.5040195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mattson, William. "Global Pharma 20/20." Journal of Pharmaceutical Marketing & Management 10, no. 2/3 (March 22, 1996): 3–18. http://dx.doi.org/10.1300/j058v10n02_02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jain, Abhinandan K., G. Raghuram, and Pramod K. Agrawal. "Kalyan Pharma Ltd." Vikalpa: The Journal for Decision Makers 18, no. 3 (July 1993): 37–48. http://dx.doi.org/10.1177/0256090919930305.

Full text
Abstract:
The case presented in this issue focuses on the interaction between the logistics and marketing aspects of KPL�a frontrunner in the pharmaceutical industry. The key strategic question is what distribution system to have to ensure good customer service as well as improved profitability. Readers are requested to send their responses on the case to Vikalpa office.
APA, Harvard, Vancouver, ISO, and other styles
6

Bajaj, Hrithik. "E-Pharma System." International Journal for Research in Applied Science and Engineering Technology 9, no. VII (July 31, 2021): 3724–27. http://dx.doi.org/10.22214/ijraset.2021.37172.

Full text
Abstract:
The primary goal of this program's development is to deliver all medical-related solutions in a single web application. E-Pharma is a platform that allows patients and doctors to communicate directly with one another. Direct doctor-patient relationships, consumer familiarity with online purchases, the simplicity of mail-order trading, and distance marketing can all help patients self-diagnose. The patient can speak with the doctor and ask questions.
APA, Harvard, Vancouver, ISO, and other styles
7

Walther, Hans-Peter, and Peter Wahle. "Strategisches Pharma-Marketing. Chance in turbulenter Umwelt." Marketing ZFP 12, no. 1 (1990): 31–40. http://dx.doi.org/10.15358/0344-1369-1990-1-31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Pharma marketing techniques might improve drug safety." Reactions Weekly &NA;, no. 1232 (December 2008): 1. http://dx.doi.org/10.2165/00128415-200812320-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bhardwaj, Shubham, Rajeshwar Verma, Romil Sharma, and Rahul Solakhia. "PHARMACOVIGILANCE: DYNAMICS IN INDIAN PHARMA INDUSTRY." Indian Journal of Pharmaceutical and Biological Research 6, no. 01 (March 31, 2018): 30–33. http://dx.doi.org/10.30750/ijpbr.6.1.5.

Full text
Abstract:
Pharmacovigilance refers to the process of identifying, detecting, and responding to drug safety issue and has witnessed dynamic advancements in pharmaceutical industries throughout the world. The main objective of pharmacovigilance is to extend the safety monitoring and to detect any ADRs that previously got unrecognized in evolution during clinical trial. ADRs monitoring is required for each medicine throughout its lifecycle which includes early stage of drug design, clinical trials, and post marketing surveillance. The emerging trend in pharmacovigilance is to link the pre marketing data with the data collected during post marketing phase that include safety information. India is a vast country with population of over 1.32 Billion with different social economics status, different patterns of disease prevalence it becomes more important to have a standardized and robust pharmacovigilance. Pharmacists, as doctor remark that their involvement may increase the reporting rate and have a greater role to play in the area of pharmacovigilance
APA, Harvard, Vancouver, ISO, and other styles
10

Obara, Naoshi, Haruhiko Ninomiya, Shigeru Chiba, Kensuke Usuki, Kaichi Nishiwaki, Itaru Matsumura, Tsutomu Shichishima, et al. "Analysis of 3 Year Post Marketing Surveillance of Eculizumab in Japan." Blood 124, no. 21 (December 6, 2014): 4870. http://dx.doi.org/10.1182/blood.v124.21.4870.4870.

Full text
Abstract:
Abstract Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a disease characterized by chronic complement-mediated hemolysis, leading to life-threatening events, such as thromboembolism (TE) and chronic kidney disease (CKD), and devastated quality of life (QOL). The terminal complement inhibitor eculizumab (ECU) was approved in Japan in 2010 under the indication to suppress hemolysis in PNH. We comprehensively report as post marketing surveillance (PMS) on the efficacy and safety of ECU administered from June 2010 to March 2013 in Japanese patients with PNH. In spite of complete blocking hemolysis, the degree of improvement of anemia by ECU treatment varies patient by patient. Analyzing the data of PMS, we investigated if patient characteristics, such as LDH, bone marrow function and renal function, can affect anemia in PNH patients treated with ECU. Methods: The PMS data of 242 patients were used for demographics and safety assessment. Of 242, 144 patients with ECU treatment at least for 1 year were analyzed for efficacy evaluation. We used platelet (PLT) count as a marker of bone marrow function and divided it into three groups, <88 (Low), 88-155 (Mid) and ≧155 x109/L (High). We also utilized CKD stage calculated by estimated GFR (eGFR) which is widely accepted as a renal function classification, eGFR <60 (CKD stage 3-5), 60-90 (CKD stage 2) and ≧90 mL/min/1.73m2 (CKD stage 0/1), according to Japanese CKD guideline. Results: In Japan LDH>1000 IU/L is commonly considered as ECU applicable severe PNH patients, but this was not correlated with other markers related to PNH severity. 41.2% of patients who started ECU had eGFR <60 mL/min/1.73m2, CKD stage 3-5. The prevalence of CKD stage 3-5 in PNH population was much higher than that of the normal Japanese population, especially in PNH patients over 65 years old. ECU treatment dramatically and quickly reduced the serum level of LDH, and 18-month (median)-teatment with ECU increased hemoglobin level by 1.9 g/dL, reduced annual transfusion units by half, made 55.3% of transfusion-dependent patients transfusion-independent, improved one CKD stage in 29% of the patients with CKD stage 3-5 and made 14% returned to CKD stage 2. Side effects of all grades associated with ECU were reported in 36.8% of patients and severe ones were observed in 8.3%, which include 10 infectious events in 8 patients. 18-month-treatment with ECU increased hemoglobin (Hb) level by 1.2 g/dL in the Low-PLT, 1.5 g/dL (p<0.001) in the Mid-PLT and 2.9 g/dL (p<0.001) in the High-PLT group and reduced annual RBC transfusion (TF) unit 21.6→11.3 (p=0.002), 11.0→7.0 and 10.0→1.1 (p<0.001), respectively. ECU augmented Hb level by 2.4 g/dL (p<0.001) in CKD stage 0/1, 2.3 g/dL (p<0.001) in CKD stage 2 and 1.1 g/dL (p=0.022) in CKD stage 3-5 and decreased annual TF units 13.4→2.9 (p<0.001), 11.5→3.3 (p=0001) and 16.5→10.4 (p=0.036), respectively. Conclusion: ECU treatment for 18 months reduced hemolysis and improved anemia, renal function and QOL. It is concluded that ECU is safe and well tolerated. Anemia in PNH would be caused not only by hemolysis but also modified by bone marrow as well as renal function. Disclosures Obara: Alexion Pharma: Research Funding. Ninomiya:Alexion Pharma: Honoraria, Research Funding. Chiba:Alexion Pharma: Research Funding. Usuki:Alexion Pharma: Speakers Bureau. Shichishima:Alexion Pharma: Honoraria, Research Funding. Nishimura:Alexion Pharma: Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau. Ohyashiki:Alexion Pharma: Honoraria, Research Funding. Nakao:Alexion Pharma: Honoraria, Research Funding. Ando:Alexion Pharma: Research Funding. Kawaguchi:Alexion Pharma: Honoraria, Research Funding. Nakakuma:Alexion Pharma: Honoraria. Hamada:Alexion Pharma: Employment. Shimono:Alexion Pharma: Employment. Kinoshita:Alexion Pharma: Honoraria. Ozawa:Alexion Pharma: Honoraria. Omine:Alexion Pharma: Honoraria. Kanakura:Alexion Pharma: Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharma marketing"

1

Wolff, Michael. "Pharma-Marketing und Umwelt : mehrdeutige Information als Auslöser einer neuen Semantik d. Arzneimittels /." Spardorf : Wilfer, 1987. http://www.gbv.de/dms/bs/toc/027210081.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tatarová, Jana. "Adaptace marketingové strategie firmy GEHE Pharma pro český trh." Master's thesis, Vysoká škola ekonomická v Praze, 2009. http://www.nusl.cz/ntk/nusl-76536.

Full text
Abstract:
This thesis is focused on adaptation of GEHE Pharma marketing strategy on the Czech wholesaler's market with pharmaceutical products. In the first part the theoretical background needed for the application part of the thesis is summarized. I mention here the possibilities of internationalization, visions and targets of the firms working on the foreign markets and basic analyses needed for acting there. Then I summarize the possibilities of adaptation of the marketing mix mention the specifics of the B2B and the pharmaceutical market. In the following application part GEHE Pharma Company is presented and also her acting on the pharmaceutical market. Then the concrete analyses are made (PEST analysis, SWOT analysis, and Czech pharmaceutical market analysis) and the adaptation of marketing mix of the company was summarized. In the last part of the thesis some suggestions for ameliorations of particular parts of marketing mix are made.
APA, Harvard, Vancouver, ISO, and other styles
3

BM, Khalid, and Priyanka Pulikanti Rani. "Impact of COVID-19 on pharmaceuticals industry to adapt digital marketing." Thesis, Högskolan i Gävle, Avdelningen för ekonomi, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:hig:diva-35234.

Full text
Abstract:
This master thesis was prompted by the overall interest in Digital marketing that has been growing since the last decade. During this pandemic time, we are interested to know about the impact of COVID-19 on pharmaceutical industry. Most of the articles and the reports in the early stage were mainly about the concept of digital marketing, technology, implementation in day-to-day business. Lesser studies have been conducted keeping the pandemic in view. Covid-19 is the most influencing topic today around the world and because of this, digital marketing has become the important marketing strategy for every business to withstand in the market.  We have chosen to work with the pharmaceutical company in an emerging country India to study the impact of Covid-19 on the pharmaceutical industry and how the industry is adapting digital marketing as their marketing strategy. The empirical study is designed as a qualitative method. We had conducted the interview with the employees of the marketing department, used digital marketing concepts from different literature, and applied to our study. We have also explained the selected methodology to answer our research questions.  Our findings from the research have shown that digital marketing is the most effective marketing strategy for almost all businesses during this lockdown. The company we worked is believing that digital marketing has a long-run result. We had discussed about the marketing challenges faced by the pharmaceutical companies during pandemic, challenges of adopting digital transformation, strategies followed by the company to sustain customer loyalty by following the aspects of relationship marketing. Our research also focused to know about the solutions to overcome the challenges faced by the pharmaceutical companies.
APA, Harvard, Vancouver, ISO, and other styles
4

Zavřelová, Tereza. "Návrh komunikační strategie produktu." Master's thesis, Vysoké učení technické v Brně. Fakulta podnikatelská, 2015. http://www.nusl.cz/ntk/nusl-224952.

Full text
Abstract:
This master´s thesis deals with improving communication strategy of Lactacyd, which is an intimate hygiene brand of Omega Pharma company. The thesis is divided into three main parts. The first part contains description of theoretical resources and fundamental knowledge. The second part of the thesis is focused on an analysis of the current situation with an aim to obtain information needed for proposal part. The last part delivers proposals for improvement of the current marketing communication as well as other proposals which can strenghten market position of Lactacyd brand.
APA, Harvard, Vancouver, ISO, and other styles
5

Tozlikian, Shant, and Erik Falk. "Marketing of Nicotine Replacement Therapy Products in a Deregulated Swedish Pharmacy Market." Thesis, Mälardalen University, School of Sustainable Development of Society and Technology, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-5675.

Full text
Abstract:

 

 

 

 

 

 

 

 

The thesis will provide a description of the previous Swedish NRT marketing mix, a description of the present plans of Swedish NRT marketers for the marketing mix of their products, and the present marketing mix of the previously deregulated pharmacy markets in Finland and Norway. The purpose is to develop conclusions on how marketers of NRT products could change their marketing mix in response to the deregulation of the Swedish pharmacy market. 

 

This thesis relies on a descriptive method. Interviews are used as the source of primary data. This is because some of the information sought after is not readily available and cannot be found through secondary data.

Markets are mature only in the minds of the actors on the market. Due to the deregulation the market seems to be a window of opportunity for any innovative, aggressive marketing entrepreneur who wants to radically change his or her position in the market. NRT marketers could attempt to design a new, more aggressive strategy and work with the remaining Ps to unhinge what seems to be regarded a mature market. NRT marketers should work more actively to create an effective market feedback loop. NRT marketers should consider using the Internet to sell their products to consumers, thus opening a new channel.

APA, Harvard, Vancouver, ISO, and other styles
6

Čapková, Martina. "Možnosti marketingové orientace ve farmacii." Master's thesis, Vysoká škola ekonomická v Praze, 2011. http://www.nusl.cz/ntk/nusl-113494.

Full text
Abstract:
The thesis deals with the topic of pharmaceutical marketing. Pharmaceutical marketing uses many usual marketing techniques, but it has also its typical characteristics. The thesis focuses on those specifics. It deals with the various tools of marketing and communication mix and their specific characteristics in relation to the pharmaceutical marketing. The thesis summarizes the theoretical literature, which relates to the topic, and explains the Czech legislation that regulates significantly all marketing activities in pharmaceutical industry. The analytical part of the thesis solves two real existing marketing problems on the example of the Belupo company. It analyses why the Simbela product has failed on the Czech market and proposes a go-to-market strategy for the new Belohair product.
APA, Harvard, Vancouver, ISO, and other styles
7

Johnson, Jeffrey A. (Jeffrey Allen) 1964. "A comparison of satisfaction with pharmacy services between mail and traditional pharmacy patrons and an evaluation of the relationship with health status." Diss., The University of Arizona, 1996. http://hdl.handle.net/10150/290607.

Full text
Abstract:
The aims of this research were to determine the level of satisfaction with pharmacy services among enrollees of a managed care organization, compare the level of satisfaction between mail pharmacy and traditional pharmacy patrons, and evaluate the relationship between satisfaction with pharmacy services and health status. Data was collected via telephone interviews with 1,362 enrollees of the managed care organization. The overall response rate was 65%. Satisfaction was measured using previously developed items for traditional pharmacy services, and newly developed, parallel items for mail pharmacy services. Scores were calculated for hypothesized multi-item dimensions of satisfaction. Health status was measured using the physical and mental health composite scores of the SF-12 Health Survey. Satisfaction with pharmacy services was compared between patron groups using ANOVA and ANCOVA models. Confirmatory factor analysis and structural equation modeling (SEM) were used to evaluate the dimensional structure of satisfaction with pharmacy services and the relationship between satisfaction with pharmacy services and health status. The results indicated that mail pharmacy patrons were more satisfied than traditional pharmacy patrons with their pharmacy services in general, and specifically with the financial aspects and technical quality of those services. When the comparisons were adjusted for general satisfaction with medical care and mental health status, mail pharmacy patrons still had greater levels of general satisfaction with pharmacy services. However, when these covariates were included in the comparison of satisfaction with financial aspects and technical quality of pharmacy services, dimension scores between the two patron groups were not significantly different. Internal consistency reliability coefficients for the multi-item dimensions of satisfaction were in the range of 0.53 to 0.77, with the exception of the Written Information dimension for mail pharmacy service, where the alpha coefficient was 0.37. A positive correlation between the dimension scores for general satisfaction with pharmacy services and general satisfaction with medical care lends support to the construct validity of the measurements. Additionally, it was concluded that, as expected, general satisfaction with pharmacy services was positively correlated with mental health status, but there was no significant relationship between physical health and satisfaction with pharmacy services.
APA, Harvard, Vancouver, ISO, and other styles
8

Futter, William Thomas. "An analysis of the relationship between the sources of conflict and the stages in the conflict process within the marketing channel comprising retail pharmacy managers and medical doctors." Thesis, Rhodes University, 1988. http://hdl.handle.net/10962/d1001628.

Full text
Abstract:
Marketing channels have traditionally been examined as commercial conduits the sale objective of which was to facilitate the flow of goods from producer to consumer. This approach emphasized functional and structural aspects of the channel and was primarily concerned with the efficiency of the distribution system. During the last two decades, marketing channels have increasingly been viewed as social systems affected by the behavioural dimensions of power, conflict, roles and communication. The rapid growth of vertical marketing systems with greater authority and interdependence between channel members, have stimulated interest in this field. Nevertheless, research has been limited and characterized by methodological problems and conceptual differences about the definitions of behavioural variables and their relationships. Some attempts have been made to develop an integrated framework within which to conduct research into channel relationships, but the validity and relaibility of these models has not been tested. This research project examined the relationship between the sources of conflict and stages in the conflict process. The sources of conflict were subdivided into attitudinal and structural categories, the latter being concerned with goal differences, the desire for autonomy in the face of interdependence and competition for scarce resources. The conflict process model adopted by the author assumes the existence of stages of latency, feeling, perception, manifestation and aftermath in each conflict episode. The first four were treated as separate behavioural states for which different levels of conflict intensity were measured. In order to provide greater explanatory power to the results of the analysis, the perceptions of two respondent groups were identified, namely the leader group, consisting of channel members responsible for the overall strategic interests of the channel, and the affected group, consisting of channel members who had been adversly affected by the activities of their partners in the channel dyad. In addition, respondents were asked to identify separately, their perceptions of the macro and micro levels of conflict in the four conflict states. The marketing channel for prescription medicines was selected for the study. The focal dyad consisted of retail pharmacy managers and doctors with single respondent perceptual measures being obtained from the retail pharmacy managers. A mail survey of all the retail pharmacy managers in South Africa, South West Africa/Namibia, and the independent homelands conducted in July 1987 resulted in a 40% response rate (1031 returns). Tests indicated statistically significant differences between the perceptual measures representing the sources and stages of conflict, the macro and micro levels of the stages of conflict and between the leader and the non-leader groups and the affected and non-affected groups. A sequential hierarchy in the level of conflict measured in the behavioural states was indicated, with decreasing levels of conflict being identified in states of latency, perception, feeling and manifestations, respectively. An analysis of the results revealed that attitudinal sources of conflict were more important that structural sources in measures of perceptions, feelings and manifestations of conflict behaviour. In the latent conflict state, structural sources assumed greater importance than attitudinal sources. In most of the measures, the sources of conflict were more correlated with perceptions of conflict at the macro level than the micro level. The exception was manifest conflict for which micro conflict levels were more important. The major sources of conflict were differences in perceptions, differences in goals and the lack of autonomy. The leader group indicated a particular concern for attitudinal factors, particularly communication difficulties. The affected group, whilst identifying attitudinal factors as being the most important, was especially concerned with their lack of autonomy from the doctor, rather than the competition for scarce resources which could have been expected. An overall assessment of the level of conflict between retail pharmacy managers and doctors indicated that the channel dyad was relatively free from conflict. Relationships were characterized by a degree of satisfaction, some degree of harmony and little evidence of conflict behaviour.
APA, Harvard, Vancouver, ISO, and other styles
9

Kuršelis, Vytautas. "MARKETINGO ELEMENTŲ ĮTAKOS VERTINIMAS PACIENTŲ APSISPRENDIMUI ĮSIGYJANT VAISTUS." Master's thesis, Lithuanian Academic Libraries Network (LABT), 2014. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2014~D_20140618_233516-71868.

Full text
Abstract:
Tyrimo tikslas – ištirti ir įvertinti marketingo elementų įtaką pacientų apsisprendimui įsigyjant vaistus. Tyrimo uždaviniai. Nustatyti kaip marketingo elementai (6p – kaina, produktas, pateikimas, rėmimas, procesai ir žmonės) lemia pacientų apsisprendimą įsigyti vaistus; įvertinti, kurie marketingo elementai yra lemiantys; nustatyti farmacinės paslaugos poveikį marketingo procese; įvertinti galimą marketingo elementų poveikio riziką. Tyrimo metodika. Tyrimas atliktas 2012 m. - 2014 m. Buvo organizuoti du tyrimo etapai – kokybinis ir kiekybinis tyrimai. Kokybiniame tyrime dalyvavo 14 vaistinės pacientų, („focus“ grupė); kiekybiniame – 381 vaistinių pacientai. Kokybiniam tyrimui taikytas turinio analizės („Content“) metodas. Statistinė duomenų analizė atlikta, naudojantis SPSS.21. Kiekybinio tyrimo duomenims vertinti taikyti faktorinės ir vidutinių įverčių analizės metodai. Rezultatai. 70,6% respondentų vaistinėje perka vaistus. Vidutiniškai vienas pacientas vieno apsipirkimo metu išleidžia 31 – 50 Lt. Dauguma vaistus perka kas mėnesį. Vaistai perkami paskyrus gydytojui (74,8%), 32% savigydos atveju, 24,4 % perka patarus vaistininkui. 66% pacientų yra bent kartą nusipirkę daugiau vaistų nei reikėjo dėl taikytos nuolaidos. 12,4 % respondentų teigė nusipirkę vaistų dėl reklamos ir informacijos internete ir nusivylę jų poveikiu. Svarbiausi paciento apsisprendimą įsigyti vaistus lemiantys marketingo elementai - farmacinė paslauga, vaistinė ir kaina. Farmacinė paslauga... [toliau žr. visą tekstą]
Objective: Investigate and evaluate the influence of marketing elements on patient's decision to purchase medicines. Methods: The study was carried out in 2013 – 2014. It was organized in two phases - qualitative and quantitative research. In the Qualitative research was conducted 14 pharmacy’s patients (the Focus Group); in the quantitative - 381 pharmacy patients. All collected qualitative data was analyzed by content analysis. An anonymous questionnaire was used for qualitative research. Statistical analysis of the quantitative findings was performed using the data analysis software package SPSS version 21. The quantitative survey data to assess the factor applied to the average of estimates and analysis. Factor analysis and average mean methods were applied to evaluate the quantitative research data. Results: 70.6 % of the respondents buy medicines in a pharmacy. On average, one patient spends 31-50 Lt. Most of the patients buy every month. The medicines are purchased because of doctor prescription (74.8 %), self-curing (32%), pharmacists’ advice (24.4%). 66 % of the patients purchased more medicines than necessary because of an applied discount at least once. 12.4 % of respondents, who have bought medicines because of advertising and information on the internet, were disappointed with the effect of these medicines. The patient's decision is mainly due to a pharmaceutical service, pharmacy and price. The pharmaceutical service is more relevant to women and younger... [to full text]
APA, Harvard, Vancouver, ISO, and other styles
10

Suttner, Raymond Sharl. "An analysis of the influence exerted by the pharmacist and pharmacy assistant in the purchase decision of health and beauty aid products." Thesis, Rhodes University, 1986. http://hdl.handle.net/10962/d1004383.

Full text
Abstract:
[Introduction] The 1980s have ushered in an era of extreme competitive pressure for the modern business organisation. In previous times many business organisations have succeeded simply because of the excellence of their products, with little concern or attention being paid to the wants and needs of potential customers. As the business environment has become more competitive, however, the point of focus has changed. There is ample evidence which suggests a correlation between success in business and firms which have adopted a marketing-orientated philosophy of business. The evolution of marketing as a discipline has been hastened in recent times by the need of the firm to survive in the face of increasing competition. This "increasing attention" is occurring because of the realisation that sheer product excellence alone will not necessarily mean that the firm will succeed in establishing a group of satisfied customers in the long term. It is the adoption of the so-called "marketing concept" which provides the opportunity for the firm to develop a competitive edge which will more likely eventuate in success.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pharma marketing"

1

Harms, Fred, Dorothee Gänshirt, and Robin Rumler, eds. Pharma-Marketing. Berlin, Boston: De Gruyter, 2008. http://dx.doi.org/10.1515/9783110504040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dichtl, Erwin, Hans Raffée, and Michael Thiess, eds. Innovatives Pharma-Marketing. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Gabler, 2011. http://dx.doi.org/10.1007/978-3-8349-6559-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Gabler Verlag, 2013. http://dx.doi.org/10.1007/978-3-8349-4571-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Springer Fachmedien Wiesbaden, 2018. http://dx.doi.org/10.1007/978-3-658-18482-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gehrig, Walter. Pharma-Marketing: Instrumente, Organisation und Methoden : national und international. Zürich: Verlag Moderne Industrie, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Walther, Hans-Peter. Erfolgreiches strategisches Pharma-Marketing: Eine theoriegeleitete empirische Studie auf der Grundlage des situativen Ansatzes. Frankfurt am Main: Lang, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Becker, Helmut E. Kommunikations-Strategien im Pharma-Markt: Verhaltenswissenschaftliche Ansätze zur Ärzte- und Patienten-Ansprache im Markt für verschreibungspflichtige Präparate. Heidelberg: Physica, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Umbach, Günter. Erfolgreich im Pharma-Marketing: Wie Sie im Produktmanagement von Arzneimitteln Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen. Wiesbaden: Springer Fachmedien, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Holdford, David A. Marketing for pharmacists. 2nd ed. Washington, DC: American Pharmacists Association, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pharma marketing"

1

Krafft, Manfred. "Pharma-Marketing." In Branchenspezifisches Marketing, 635–59. Wiesbaden: Gabler Verlag, 2001. http://dx.doi.org/10.1007/978-3-663-09439-5_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Harms, Fred. "Einleitung: Evolution zum innovativen Marketing." In Pharma-Marketing, edited by Fred Harms, Dorothee Gänshirt, and Robin Rumler, 1–6. Berlin, Boston: De Gruyter, 2008. http://dx.doi.org/10.1515/9783110504040-003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Crisand, Marcel. "Zielgruppenspezifisches Marketing gegenüber Ärzten als zentraler Baustein des Marketing der Pharma-Industrie." In Pharma-Trends und innovatives Pharma-Marketingmanagement, 171–244. Wiesbaden: Gabler Verlag, 1996. http://dx.doi.org/10.1007/978-3-322-89162-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Umbach, Günter. "Marketing-Fachwissen." In Erfolgreich im Pharma-Marketing, 39–92. Wiesbaden: Gabler, 2011. http://dx.doi.org/10.1007/978-3-8349-6559-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Umbach, Günter. "Marketing-Fachwissen." In Erfolgreich im Pharma-Marketing, 39–92. Wiesbaden: Springer Fachmedien Wiesbaden, 2017. http://dx.doi.org/10.1007/978-3-658-18482-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dams, Vok. "Electronic-Marketing — Eine neue Komponente im Pharma-Marketing-Mix." In Handbuch Pharma-Management, 729–43. Wiesbaden: Gabler Verlag, 1995. http://dx.doi.org/10.1007/978-3-322-90784-4_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilkes, Malte W. "Wertewandel in Marketing und Medizin — Konsequenzen für das Pharma-Marketing." In Innovatives Pharma-Marketing, 83–95. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kießling, Günter. "Markenbildung im veränderten Pharma-Umfeld." In Innovatives Pharma-Marketing, 303–16. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Raffée, Hans, and Michael Thiess. "Herausforderungen an das Pharma-Marketing der 90er Jahre." In Innovatives Pharma-Marketing, 1–16. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

von Keitz, Beate, and Gerald Kosaris. "Blickaufzeichnungstests — Wie betrachtet der Arzt die Anzeige?" In Innovatives Pharma-Marketing, 201–20. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharma marketing"

1

Ignjatović, Dejana, and Milenko Stanić. "Contemporary Marketing in Pharmacy With the Focus on the E- Pharmacy Concept." In FINIZ 2019. Belgrade, Serbia: Singidunum University, 2019. http://dx.doi.org/10.15308/finiz-2019-78-84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Riantini, Regina Eka. "How Pharmaceutical Consumers in Jakarta Adopt New Marketing Technology: Digital Pharmacy Mobile Application." In 2020 International Conference on Information Management and Technology (ICIMTech). IEEE, 2020. http://dx.doi.org/10.1109/icimtech50083.2020.9211215.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Puras, Gustavo, Jesús Ciriza, and Laura Saenz Del Burgo. "THE USE OF PROBLEM-BASED LEARNING METHODOLOGY IN ORDER TO ACQUIRE MARKETING TOOLS TO BE USED AT THE COMMUNITY PHARMACY." In International Conference on Education and New Learning Technologies. IATED, 2017. http://dx.doi.org/10.21125/edulearn.2017.0952.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharma marketing' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography